SCHEMBL9510855

SCHEMBL9510855

CC(C)OP(=O)(CC(=O)NC1CC1)OC(C)C

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
MMP2 P08253 3/20 0.37
MMP8 P22894 1/20 0.37
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
LMNA P02545 1/20 0.36
ATF4 P18848 1/20 0.36
SMYD3 Q9H7B4 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 2/20 0.35
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
TSHR P16473 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8442550 0.77 MMP2 (0.46) NPSR1KMT2AL3MBTL1MMP2MMP8
SCHEMBL6762220 0.72 EPHX2 (0.43) NPSR1L3MBTL1MMP2MMP8LMNA
SCHEMBL7573633 0.71 MMP2 (0.52) KMT2AMMP2MMP8CA12CA1
SCHEMBL14671386 0.71 MMP2 (0.41) NPSR1KMT2AL3MBTL1MMP2MMP8
SCHEMBL13681670 0.71 NPSR1 (0.52) NPSR1KMT2AL3MBTL1LMNAATF4
SCHEMBL12446601 0.70 MMP2 (0.57) NPSR1KMT2AMMP2MMP8CA12
SCHEMBL2717779 0.70 POLB (0.40) KMT2AMMP2MMP8CA12CA1
SCHEMBL8866823 0.69 CTSA (0.39) L3MBTL1TSHR
SCHEMBL8002995 0.69 TDP1 (0.40) KMT2AL3MBTL1LMNAHPGDTSHR
SCHEMBL18199497 0.67 RAB9A (0.49) NPSR1KMT2AL3MBTL1LMNASMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569409-A1 AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE THE WELLCOME FOUNDATION LIMITED (GB) 1993-11-18 EP disclosed
WO-1992012959-A1 AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE THE WELLCOME FOUNDATION LIMITED (GB) 1992-08-06 WO disclosed